[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2008030838A3 - Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p) - Google Patents

Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p) Download PDF

Info

Publication number
WO2008030838A3
WO2008030838A3 PCT/US2007/077581 US2007077581W WO2008030838A3 WO 2008030838 A3 WO2008030838 A3 WO 2008030838A3 US 2007077581 W US2007077581 W US 2007077581W WO 2008030838 A3 WO2008030838 A3 WO 2008030838A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
sphingosine
phosphate
biological activity
receptor agonist
Prior art date
Application number
PCT/US2007/077581
Other languages
English (en)
Other versions
WO2008030838A2 (fr
Inventor
Richard L Beard
John E Donello
Haiqing Yuan
Xiaoxia Liu
Original Assignee
Allergan Inc
Richard L Beard
John E Donello
Haiqing Yuan
Xiaoxia Liu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc, Richard L Beard, John E Donello, Haiqing Yuan, Xiaoxia Liu filed Critical Allergan Inc
Priority to BRPI0716601-0A2A priority Critical patent/BRPI0716601A2/pt
Priority to EP07841847A priority patent/EP2064183A2/fr
Priority to JP2009527529A priority patent/JP2010502728A/ja
Priority to CA002662850A priority patent/CA2662850A1/fr
Priority to AU2007292436A priority patent/AU2007292436A1/en
Publication of WO2008030838A2 publication Critical patent/WO2008030838A2/fr
Publication of WO2008030838A3 publication Critical patent/WO2008030838A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

La présente invention concerne un nouveau composé ayant une activité d'agoniste du récepteur de S1P3 qui est représenté par la formule (I) dans laquelle X est choisi dans le groupe constitué par CR3, N et NO ; Y est choisi dans le groupe constitué par CR3, N et NO ; Z est choisi dans le groupe constitué par CR3, N et NO ; et au moins un parmi X, Y et Z représente N ou NO ; V représente O ou NOR4 R1 représente un groupe aryle ; R2 représente un groupe aryle ; R3 est choisi dans le groupe constitué par H et un groupe alkyle ; et 2 desdits groupes R3 peuvent former conjointement un noyau alkyle cyclique possédant de 3 à 6 atomes de carbone ; R4 est choisi dans le groupe constitué par H et un groupe alkyle ; a vaut 0 ou un nombre entier de 1 à 6 ; b vaut 0 ou 1 ; c vaut 0 ou 1 ; f vaut 0 ou un nombre entier valant 1 ou 2 ; x vaut 0 ou 1 ; y vaut 0 ou un nombre entier de 1 à 3 ; et z vaut 0 ou un nombre entier de 1 à 3.
PCT/US2007/077581 2006-09-07 2007-09-05 Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p) WO2008030838A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI0716601-0A2A BRPI0716601A2 (pt) 2006-09-07 2007-09-05 compostos de heteroaromÁticos tendo atividade biolàgica agonista de receptor de esfingosina-1-fosfato(s1p)
EP07841847A EP2064183A2 (fr) 2006-09-07 2007-09-05 Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p)
JP2009527529A JP2010502728A (ja) 2006-09-07 2007-09-05 スフィンゴシン−１−リン酸（ｓ１ｐ）受容体アゴニスト生物活性を有するヘテロ芳香族化合物
CA002662850A CA2662850A1 (fr) 2006-09-07 2007-09-05 Composes heteroaromatiques ayant une activite biologique d'agoniste de recepteur de sphingosine-1-phosphate (s1p)
AU2007292436A AU2007292436A1 (en) 2006-09-07 2007-09-05 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82480506P 2006-09-07 2006-09-07
US60/824,805 2006-09-07

Publications (2)

Publication Number Publication Date
WO2008030838A2 WO2008030838A2 (fr) 2008-03-13
WO2008030838A3 true WO2008030838A3 (fr) 2008-11-27

Family

ID=39157985

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/077581 WO2008030838A2 (fr) 2006-09-07 2007-09-05 Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p)

Country Status (6)

Country Link
EP (1) EP2064183A2 (fr)
JP (1) JP2010502728A (fr)
AU (1) AU2007292436A1 (fr)
BR (1) BRPI0716601A2 (fr)
CA (1) CA2662850A1 (fr)
WO (1) WO2008030838A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
JP2013512243A (ja) 2009-11-24 2013-04-11 アラーガン インコーポレイテッド 治療的有用性を有する受容体調節物質としての新規化合物
US8513220B2 (en) 2010-05-14 2013-08-20 Allergan, Inc. Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity
US20110281822A1 (en) 2010-05-14 2011-11-17 Allergan, Inc. Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058848A1 (fr) * 2003-12-17 2005-06-30 Merck & Co., Inc. Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013654A (en) * 1974-01-31 1977-03-22 Eli Lilly And Company 5,6-diaryl-1,2,4-triazines
US4021553A (en) * 1976-03-10 1977-05-03 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
DE2712694A1 (de) * 1977-03-23 1978-09-28 Degussa Verfahren zur herstellung substituierter pyridine
JP2003531202A (ja) * 2000-04-25 2003-10-21 ファルマシア・コーポレーション ３，４−ジ（カルボシクリルまたはヘテロシクリル）チオフェンの位置選択的合成
JP2008500951A (ja) * 2004-05-31 2008-01-17 田辺三菱製薬株式会社 二環化合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058848A1 (fr) * 2003-12-17 2005-06-30 Merck & Co., Inc. Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg)

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495008, Database accession no. 602026 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495009, Database accession no. 2436778 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495010, Database accession no. 4818030 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495011, Database accession no. 2532400 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495012, Database accession no. 4223051 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495013, Database accession no. 2528516 *
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002495014, Database accession no. 602032 *

Also Published As

Publication number Publication date
JP2010502728A (ja) 2010-01-28
EP2064183A2 (fr) 2009-06-03
AU2007292436A1 (en) 2008-03-13
BRPI0716601A2 (pt) 2013-09-17
WO2008030838A2 (fr) 2008-03-13
CA2662850A1 (fr) 2008-03-13

Similar Documents

Publication Publication Date Title
WO2005105732A8 (fr) Composes methylaryl- ou heteroarylamides substitues
WO2008108380A3 (fr) Composés de pyrrole
CA2565660A1 (fr) Composes aryl- ou heteroarylamides ortho-substitues
AU2001232340A1 (en) Novel isoxazole and thiazole compounds and use thereof as drugs
WO2008108378A3 (fr) Dérivé bicyclique d'oxomorpholine
WO2008081096A3 (fr) Derives quinolinyliques, leur procede de preparation. les compositions pharmaceutiques qui les contiennent et leur utilisation comme agents hypoglycemiants et hypoli pemiants
EP1798226A4 (fr) Derive de traizol
SG165361A1 (en) Antituberculous composition comprising oxazole compounds
MY158240A (en) Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
NZ596653A (en) Total synthesis of salinosporamide a and analogs thereof
DE602008005238D1 (de) Bisphenol Monoester
WO2008030838A3 (fr) Composés hétéroaromatiques ayant une activité biologique d'agoniste de récepteur de sphingosine-1-phosphate (s1p)
MY160882A (en) Biocidal composition and method
IN2015KN00276A (fr)
WO2009045988A3 (fr) Nouveaux colorants fluorescents organiques de sulfonyl uréido benzoxazinone
DE50200282D1 (de) Kohlenstoffhaltiges Material
WO2009005135A1 (fr) Agent de durcissement pour une composition de résine époxy et agent de durcissement de la résine époxy
MX2009011888A (es) Compuesto de epoxi y metodo para fabricar el mismo.
EP1493765A4 (fr) Polymeres organiques presentant a leurs extremites des groupes de silicium contenant un groupe epoxy et/ou oxetanyl, et procede de production de ces polymeres
WO2008117861A1 (fr) Agents diminuant la pression intraoculaire contenant des dérivés de phénylènediamine en tant que principe actif
EP1637526A4 (fr) Composes polycycliques durcissables et leur procede de production
ATE526313T1 (de) Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitor
EP2008995A3 (fr) Composant azoïque et procédé de préparation du composant azoïque
EP1864977A4 (fr) Nouveaux composes cycliques possedant un groupe pyrimidinylalkylthio
TW200626007A (en) Material for electroluminescent element and electroluminescent element

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07841847

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2662850

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2009527529

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007292436

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007841847

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007292436

Country of ref document: AU

Date of ref document: 20070905

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0716601

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090309